Sec. 6102. Requiring Medicare Advantage plans and part D prescription drug plans to include information on risks associated with opioids and coverage of nonpharmacological therapies and nonopioid medications or devices used to treat pain

173 words·~1 min read·/bill/115/hr/6/eah/section-6102

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 1860D–4(a)(1) of the Social Security Act ( 42 U.S.C. 1395w–104(a)(1) ) is amended— in subparagraph (A), by inserting , subject to subparagraph (C), before including ; in subparagraph (B), by adding at the end the following new clause: For plan year 2021 and each subsequent plan year, subject to subparagraph (C), with respect to the treatment of pain— the risks associated with prolonged opioid use; and coverage of nonpharmacological therapies, devices, and nonopioid medications— in the case of an MA–PD plan under part C, under such plan; and in the case of a prescription drug plan, under such plan and under parts A and B. ; and by adding at the end the following new subparagraph:

A PDP sponsor of a prescription drug plan may, in lieu of disclosing the information described in subparagraph (B)(vi) to each enrollee under the plan, disclose such information through mail or electronic communications to a subset of enrollees under the plan, such as enrollees who have been prescribed an opioid in the previous 2-year period. .

Connections1 off-index

1 reference not yet in our index

42 USC 1395w–104(a)(1)

Citation graph

cites case law

Sec. 6102

Requiring Medicare Advantage plans and part D prescription drug plans to include information on risks associated with opioids and coverage of nonpharmacological therapies and nonopioid medications or devices used to treat pain

Cite42 USC 1395w–104(a)(1)

Cites 1Cited by 0 across 0 sources